CRDO vs. PFE
Compare and contrast key facts about Credo Technology Group Holding Ltd (CRDO) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CRDO or PFE.
Correlation
The correlation between CRDO and PFE is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CRDO vs. PFE - Performance Comparison
Key characteristics
CRDO:
1.95
PFE:
-0.62
CRDO:
2.58
PFE:
-0.58
CRDO:
1.36
PFE:
0.93
CRDO:
3.24
PFE:
-0.21
CRDO:
8.01
PFE:
-0.91
CRDO:
24.70%
PFE:
13.28%
CRDO:
101.84%
PFE:
23.81%
CRDO:
-62.04%
PFE:
-58.96%
CRDO:
-39.89%
PFE:
-56.34%
Fundamentals
CRDO:
$8.27B
PFE:
$134.92B
CRDO:
$0.03
PFE:
$1.41
CRDO:
1.62K
PFE:
16.87
CRDO:
25.05
PFE:
2.17
CRDO:
13.26
PFE:
1.56
CRDO:
$266.75M
PFE:
$62.46B
CRDO:
$168.72M
PFE:
$42.09B
CRDO:
$12.63M
PFE:
$16.71B
Returns By Period
In the year-to-date period, CRDO achieves a -23.54% return, which is significantly lower than PFE's -11.99% return.
CRDO
-23.54%
45.58%
9.29%
196.88%
N/A
N/A
PFE
-11.99%
5.17%
-13.65%
-13.66%
-4.28%
0.57%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CRDO vs. PFE — Risk-Adjusted Performance Rank
CRDO
PFE
CRDO vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Credo Technology Group Holding Ltd (CRDO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CRDO vs. PFE - Dividend Comparison
CRDO has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 9.23%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRDO Credo Technology Group Holding Ltd | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 9.23% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% |
Drawdowns
CRDO vs. PFE - Drawdown Comparison
The maximum CRDO drawdown since its inception was -62.04%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for CRDO and PFE. For additional features, visit the drawdowns tool.
Volatility
CRDO vs. PFE - Volatility Comparison
Credo Technology Group Holding Ltd (CRDO) has a higher volatility of 21.64% compared to Pfizer Inc. (PFE) at 8.97%. This indicates that CRDO's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CRDO vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Credo Technology Group Holding Ltd and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRDO vs. PFE - Profitability Comparison
CRDO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Credo Technology Group Holding Ltd reported a gross profit of 85.93M and revenue of 135.00M. Therefore, the gross margin over that period was 63.7%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
CRDO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Credo Technology Group Holding Ltd reported an operating income of 26.19M and revenue of 135.00M, resulting in an operating margin of 19.4%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
CRDO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Credo Technology Group Holding Ltd reported a net income of 29.36M and revenue of 135.00M, resulting in a net margin of 21.8%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.